胃内球囊用于减重的临床研究进展  

Clinical Research Progress of the Intragastric Balloon for Weight Loss

作　　者：康军仁 徐强[2] 李海龙 魏薇 KANG Junren;XU Qiang;LI Hailong;WEI Wei(Department of Clinical Nutrition,Peking Union Medical College Hospital,Chinese Academy of Medical Sciences&Peking Union Medical College,Beijing 100730,China;Department of General Surgery,Peking Union Medical College Hospital,Chinese Academy of Medical Sciences&Peking Union Medical College,Beijing 100730,China)

机构地区：[1]中国医学科学院北京协和医院临床营养科,北京100730 [2]中国医学科学院北京协和医院基本外科,北京100730

出　　处：《协和医学杂志》2023年第3期591-597,共7页Medical Journal of Peking Union Medical College Hospital

基　　金：中央高水平医院临床科研业务费项目(2022-PUMCH-A-061)。

摘　　要：胃内球囊是一种无创的肥胖症治疗策略。通过在胃内放置球囊,限制容量和延缓胃排空可实现减重目的,临床上适用于单纯通过饮食和运动未能减重成功,或不愿意接受减重手术的肥胖症患者,也可用于减重手术术前先期减重的过渡性治疗。胃内球囊留置期内减重效果良好,严重并发症发生率低,但长期减重及改善代谢效果尚需更多临床研究加以验证。目前胃内球囊在我国尚未获批应用于临床。本文对胃内球囊的适应证、禁忌证、减重效果及相关并发症进行综述,以期指导临床实践。The intragastric balloon(IGB),a non⁃invasive temporary method for obesity,can induce weight loss by placing a soft saline⁃or air⁃filled balloon in the stomach to reduce gastric capacity and delay gas⁃tric emptying.IGB is an option for individuals with obesity who have failed at weight management with diet and exercise or are unwilling to undergo bariatric surgery.Besides,IGB can also be used as a bridging intervention prior to bariatric surgery.IGB has been proven to be effective in inducing weight loss,with a low incidence of serious complications by clinical practice from foreign countries.However,the long⁃term follow⁃up for its effects on weight loss and metabolic improvement of IGB need to be verified in the future.The IGB has not been ap⁃proved for clinical application in China.In this review,we discuss the indications and contraindications of IGB as well as its effects on weight loss and its complications.

关 键 词：胃内球囊 肥胖症 减重 治疗策略 

分 类 号：R459.3[医药卫生—治疗学] R589[医药卫生—临床医学]